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Poster background
Oxcarbazepine (OXC) is a structural analog of carbamaze-
pine (CBZ). OXC is considered a promising alternative
medication for patients who cannot tolerate CBZ because
of its equivalent clinical effiecacy and fewer cutaneous
adverse drug reactions (cADRs) compared to CBZ. HLA-
B*15:02 allele was shown to strongly associate with carba-
mazepine (CBZ)-induced Stevens-Johnson syndrome
(SJS)/toxic epidermal necrolysis (TEN) in Chinese and
Southeast Asian populations.However,the epidemiological
data about OXC-induced cADRs in recent years is limited.
This study aims to investigate the clinical characteristics of
OXC-induced cADRs and their genetic associations with
HLA-B*15:02.
Method
We conducted a perspective study of patients with OXC-
induced cADRs from Chang Gung Memorial Hospital
Health System and Taiwan-SCAR consortium since 2006
to 2013. The diagnosis of OXC-cADRs were based on
clinical features, exclusions of alternative causes, sup-
ported by ancillary investigations such as histological and
laboratory findings. Clinical course, latent period, drug
dosage, organ involvement, complications and the mortal-
ity were analyzed. We also examined the HLA-A and -B
genotypes of all patients with OXC-induced cADRs com-
paring to OXC-tolerant controls.
Results
The study included 31 patients with OXC-cADRs, includ-
ing 12 SJS (no TEN case), 4 drug rashes with eosinophilia
and systemic symptoms (DRESS ), 13 maculopapular
exanthema (MPE), 2 bullous fixed drug eruption (BFDE)
and 101 OXC-tolerant controls. Comparing to CBZ, the
clinical severity of OXC-induced SJS and DRESS were less
severe. All cases of OXC-SJS presented with limited skin
detachment (<5%) without mortality, although there were
typical mucosal involvements and typical histopathologicl
findings of epidermal necrosis. All four cases of OXC-
DRESS also presented with less severe liver injuries. Inter-
estingly, similar to CBZ-SJS, the HLA study showed HLA-
B 15:02 allele was significantly associated with patients
with OXC-SJS (P< 0.01), but was not associated with other
phenotypes. However, HLA-A*3101 was not significantly
associated with all phenotypes of OXC-cADRs.
Conclusion
Our findings suggest that HLA-B*15:02 allele is signifi-
cantly associated with OXC- SJS in Han Chinese.
However, the genetic association is phenotype-specific
(only for OXC-SJS) and the strength is less than CBZ-SJS/
TEN. Furthermore, in comparison to CBZ, OXZ-SJS
presented with less clinical severity and better clinical
outcomes, suggesting a decrease of antigenicity for induc-
tion of SJS than CBZ.
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